When someone writes a blog like this about a company, it worries me. While it is only positive rather than blatantly ramping such as those about ARBB and AGES, why is there a need to write anything about Zhulian?
It can be seen on this chat the investors tend to keep quiet and just await the expected good dividend.
Is there something wrong in the company that someone feels the need to try and preempt a selldown? Does anyone have views on this?
A quick check on yuhang99 appears that he/she does promote/ link the investmiles blogs a lot.
PS, this counter holds a significant percentage in my portfolio.
【Consolidated Statement of Profit or Loss and Other Comprehensive Income】 The Group’s revenue for the period under review was RM116.1 million, a decrease of 9% as compared topreceding year corresponding period of RM127.1 million.
Preceding year corresponding period partially spanned before the World Health Organization declared the Coronavirus (COVID-19) outbreak to be a pandemic on 11 March 2020, which has since caused severe global social and economic disruptions and uncertainties, including markets where the Group operates.
Share of profit of equity-accounted associate for the period under review was RM11.5 million, an increase of 12% as compared to preceding year corresponding period of RM10.3 million. The increase was mainly attributable to impairment of certain investment cost recorded in preceding year of which no longer recurs in the current year.
Profit before tax for the period under review was RM40.6 million, a decrease of 6% as compared to preceding year corresponding period of RM43.1 million.
【Consolidated Statement of Financial Position】 The Group’s total assets as at 31 August 2021 was RM603.0 million, a decrease of RM29.5 million from last financial year ended 30 November 2020 of RM632.5 million. The decrease was mainly attributable to the special dividend in respect of the financial year ended 30 November 2020 paid on 10 March 2021.
The Group’s total liabilities as at 31 August 2021 was RM43.2 million, a decrease of RM3.4 million from last financial year ended 30 November 2020 of RM46.6 million.
The Group’s total equity as at 31 August 2021 was RM559.8 million, a decrease of RM26.2 million from last financial year ended 30 November 2020 of RM586.0 million.
The Group’s net asset per ordinary share as at 31 August 2021 was RM1.22.
【Consolidated Statement of Cash Flows】 The Group’s cash and cash equivalents as at 31 August 2021 was RM238.7 million, an increase of RM47.0 million from last financial year ended 30 November 2020 of RM191.7 million.
The net cash inflow from the operating activities was RM110.3 million, substantially contributed by dividend received from an associate.
The net cash inflow from the investing activities was RM1.2 million.
The net cash outflow used in financing activities was RM64.5 million, mainly dividends paid to shareholders of the Group.
No point invest in this counter, their Glory age already OVER....better buy TOPGLOVE , Soon this counter price will back to Glory age trust us...TOPGLOVE this month will rose to price RM4.50....Come IB together we Push up the price to more higher than RM5.00.
my point of view their management team all are family & relatives how to improve on R&D. 2. Jewellery totally can't sell 3. Homecare products do not sell much only Ginseng coffee. onside factory in Plot 3 is almost empty and plot 42 on fake Jewellery, Water Filter, detergent & Toothpaste.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....